$RMTG
Regenerative Medical Technology Group Inc. Stock $rmtg

$rmtg Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024032991 Filed on April 15, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$817.0K	$615.6K	$2.410M
YoY Change	3.92%	13.73%	57.49%
Cost Of Revenue	$248.0K	$180.8K	$734.3K
YoY Change	-0.54%	-1.95%	12.4%
Gross Profit	$569.0K	$434.8K	$1.676M
YoY Change	6.0%	21.83%	91.08%
Gross Profit Margin	69.64%	70.63%	69.53%
Selling, General & Admin	$597.5K	$472.9K	$2.081M
YoY Change	818420.55%	12.3%	-74.62%
% of Gross Profit	105.01%	108.78%	124.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$76.57K	$96.93K	$310.1K
YoY Change	35.22%	91.71%	103.03%
% of Gross Profit	13.46%	22.3%	18.51%
Operating Expenses	$674.1K	$569.9K	$2.391M
YoY Change	10.32%	20.81%	15.96%
Operating Profit	-$105.1K	-$135.1K	-$715.2K
YoY Change	41.63%	17.66%	-39.64%
Interest Expense	-$1.856M	-$1.632M	-$6.487M
YoY Change	16.1%	72.56%	47.75%
% of Operating Profit
Other Income/Expense, Net	$503.6K	$2.460K	$503.6K
YoY Change	0.0%		0.0%
Pretax Income	-$1.961M	-$256.0K	-$9.814M
YoY Change	17.41%	-75.86%	76.03%
Income Tax			-$2.061M
% Of Pretax Income
Net Earnings	-$1.961M	-$256.0K	-$9.814M
YoY Change	17.41%	-74.2%	78.21%
Net Earnings / Revenue	-240.02%	-41.59%	-407.21%
Basic Earnings Per Share	-$0.16		-$0.79
Diluted Earnings Per Share	-$0.16	-$0.02	-$0.79
COMMON SHARES
Basic Shares Outstanding	12.49M shares	12.44M shares	12.45M shares
Diluted Shares Outstanding	12.49M shares		12.45M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$579.4K	$530.5K	$530.5K
YoY Change	-64.6%	-67.75%	-67.75%
Cash & Equivalents	$579.4K	$530.5K	$530.5K
Short-Term Investments
Other Short-Term Assets	$45.50K	$20.50K	$20.50K
YoY Change
Inventory
Prepaid Expenses	$45.50K	$20.50K
Receivables	$43.51K	$23.96K	$23.96K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$668.4K	$575.0K	$575.0K
YoY Change	-61.58%	-66.08%	-66.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$366.3K	$359.3K	$362.0K
YoY Change	129.62%	92.89%	64.38%
Goodwill	$1.680M	$1.680M
YoY Change	-71.06%	-71.06%
Intangibles	$232.2K	$256.5K
YoY Change	-29.58%	-27.55%
Long-Term Investments
YoY Change
Other Assets	$7.264K	$5.568K	$5.570K
YoY Change	30.41%	-0.04%	0.0%
Total Long-Term Assets	$2.411M	$2.304M	$2.304M
YoY Change	-61.9%	-63.92%	-63.92%
TOTAL ASSETS
Total Short-Term Assets	$668.4K	$575.0K	$575.0K
Total Long-Term Assets	$2.411M	$2.304M	$2.304M
Total Assets	$3.079M	$2.879M	$2.879M
YoY Change	-61.83%	-64.37%	-64.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$554.5K	$421.3K	$421.3K
YoY Change	48.26%	71.65%	71.65%
Accrued Expenses	$7.364M	$6.597M	$6.600M
YoY Change	35.59%	41.65%	40.72%
Deferred Revenue		$2.000K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$16.24M	$15.22M	$15.22M
YoY Change	129.75%	116.04%	116.04%
Total Short-Term Liabilities	$24.36M	$22.25M	$22.25M
YoY Change	88.42%	85.42%	85.42%
LONG-TERM LIABILITIES
Long-Term Debt	$2.430M	$2.425M	$2.425M
YoY Change	-72.36%	-69.91%	-69.91%
Other Long-Term Liabilities	$48.91K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities	$2.479M	$2.425M	$2.425M
YoY Change	-71.8%	-69.92%	-69.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.36M	$22.25M	$22.25M
Total Long-Term Liabilities	$2.479M	$2.425M	$2.425M
Total Liabilities	$26.84M	$24.67M	$24.67M
YoY Change	23.56%	22.99%	22.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.95M	-$61.99M
YoY Change	18.77%	18.81%
Common Stock	$12.49K	$12.49K
YoY Change	0.4%	0.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$23.76M	-$21.80M	-$21.80M
YoY Change
Total Liabilities & Shareholders Equity	$3.079M	$2.879M	$2.879M
YoY Change	-61.83%	-64.37%	-64.37%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.961M	-$256.0K	-$9.814M
YoY Change	17.41%	-74.2%	78.21%
Depreciation, Depletion And Amortization	$76.57K	$96.93K	$310.1K
YoY Change	35.22%	91.71%	103.03%
Cash From Operating Activities	$108.0K	-$29.40K	-$419.2K
YoY Change	1493.59%	-40.52%	-62.37%
INVESTING ACTIVITIES
Capital Expenditures	$59.15K	$284.0K	$385.6K
YoY Change	978.27%	314.43%	94.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$59.15K	-$284.0K	-$385.6K
YoY Change	978.27%	314.43%	94.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-300.0K	-$309.9K
YoY Change		4515.38%	1391.38%
NET CHANGE
Cash From Operating Activities	$108.0K	-29.40K	-$419.2K
Cash From Investing Activities	-$59.15K	-284.0K	-$385.6K
Cash From Financing Activities		-300.0K	-$309.9K
Net Change In Cash	$48.81K	-613.4K	-$1.115M
YoY Change	-670.17%	392.86%	-16.4%
FREE CASH FLOW
Cash From Operating Activities	$108.0K	-$29.40K	-$419.2K
Capital Expenditures	$59.15K	$284.0K	$385.6K
Free Cash Flow	$48.81K	-$313.4K	-$804.8K
YoY Change	3686.81%	165.69%	-38.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12219502	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.79
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12447089	shares
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56010
CY2023	dei	Entity Registrant Name EntityRegistrantName	MESO NUMISMATICS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0492191
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	433 Plaza Real Suite 275
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33432
CY2023	dei	City Area Code CityAreaCode	(800)
CY2023	dei	Local Phone Number LocalPhoneNumber	956-3935
CY2023	dei	Security12b Title Security12bTitle	None
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	612544	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12493938	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	Victor Mokuolu, CPA PLLC
CY2023	dei	Auditor Location AuditorLocation	Houston, Texas
CY2023	dei	Auditor Firm AuditorFirmId	6771
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	530540	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1645185	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	23956	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	49766	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	20500	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	574996	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1694951	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	359303	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	186269	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5568	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5568	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	256544	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	354084	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2714	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33963	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1679978	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5805438	usd
CY2023Q4	us-gaap	Assets Assets	2879103	usd
CY2022Q4	us-gaap	Assets Assets	8080273	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	421334	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	245463	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6597422	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4657530	usd
CY2023Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	2000	usd
CY2022Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	10450	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2146	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	6944	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2714	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	32568	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	15223519	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7046666	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22249135	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11999621	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1395	usd
CY2023Q4	mssv	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	35023	usd
CY2022Q4	mssv	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	37419	usd
CY2023Q4	mssv	Notes Payable Net Of Discount NotesPayableNetOfDiscount	2382648	usd
CY2022Q4	mssv	Notes Payable Net Of Discount NotesPayableNetOfDiscount	8016330	usd
CY2023Q4	us-gaap	Liabilities Liabilities	24674605	usd
CY2022Q4	us-gaap	Liabilities Liabilities	20062565	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12493938	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12493938	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12443938	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12443938	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12494	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12444	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40181074	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40180669	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61990131	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52176465	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-21795503	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11982292	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2879103	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8080273	usd
CY2023	us-gaap	Revenues Revenues	2409953	usd
CY2022	us-gaap	Revenues Revenues	1530223	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	734285	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	653256	usd
CY2023	us-gaap	Gross Profit GrossProfit	1675668	usd
CY2022	us-gaap	Gross Profit GrossProfit	876967	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	476989	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	317796	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	752277	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	886651	usd
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	90000	usd
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	90000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	310102	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	152739	usd
CY2023	mssv	Investor Relations InvestorRelations	9000	usd
CY2022	mssv	Investor Relations InvestorRelations	190382	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	752527	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	424258	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2390894	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2061826	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	6491538	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	4403774	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	4798	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	13498	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2463	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1511297	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	4125460	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9813666	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5575135	usd
CY2022	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	68313	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	68313	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9813666	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5506822	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.79
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.46
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.79
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12447089	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12219502	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11982292	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	455	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9813666	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-21795503	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-6757006	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	30000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	251536	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5506822	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11982292	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9813666	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5575135	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3059914	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1756764	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	310102	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	152739	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	4798	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	13498	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	455	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	10000	usd
CY2023	mssv	Gain On Settlement Of Debt GainOnSettlementOfDebt	2463	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1511297	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4125460	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-25810	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	32510	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	20500	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3411783	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2517791	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-419200	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1183849	usd
CY2022	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	1400	usd
CY2022	mssv	Gainloss On Discontinued Operations GainlossOnDiscontinuedOperations	68313	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	69713	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-419200	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1114136	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	385596	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	198428	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-385596	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-198428	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	9850	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	20776	usd
CY2023	mssv	Consideration Paid To Note Holder ConsiderationPaidToNoteHolder	300000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-309850	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20776	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1114645	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1333340	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1645185	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2978525	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	530540	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1645185	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	446	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	283	usd
CY2023	mssv	Stock Issued Through Stock Payable StockIssuedThroughStockPayable	455	usd
CY2022	mssv	Stock Issued Through Stock Payable StockIssuedThroughStockPayable	271536	usd
CY2022	mssv	Right Of Use Asset Financed Through Payable RightOfUseAssetFinancedThroughPayable	62903	usd
CY2023	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On July 2, 2018, the Board of Directors authorized and shareholders approved a 1-for-1,000 reverse stock split of its issued and outstanding shares of common stock held by the holders of record. The prior year financials have been changed to reflect the 1-for-1,000 reverse stock split.
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Use of Estimates in Financial Statement Presentation</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The significant estimates included in these financial statements are associated with accounting for the goodwill, derivative liability, valuation of preferred stock, and for the valuation of assets and liabilities in business combination.</p>
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Reclassifications</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain amounts for the prior year have been revised or reclassified to conform to the current year presentation. No change in net loss resulted from these reclassifications.</p>
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	126884881	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	143312746	shares
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	2146	usd
CY2023Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	2146	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	6944	usd
CY2022Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	6944	usd
CY2023	mssv	Going Concern GoingConcern	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Going Concern</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred losses since inception, resulting in an accumulated deficit of $61,990,131 and a working capital deficit of $21,674,139 as of December 31, 2023 and future losses are anticipated. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ability of the Company to continue its operations as a going concern is dependent on management’s plans, which include the raising of capital through debt and/or equity markets with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will require additional funding to finance the growth of its current and expected future operations as well to achieve its strategic objectives. There can be no assurance that financing will be available in amounts or terms acceptable to the Company, if at all. The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. </p>
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61990131	usd
CY2023Q4	mssv	Working Capital Deficit WorkingCapitalDeficit	21674139	usd
CY2023	us-gaap	Revenues Revenues	2409953	usd
CY2022	us-gaap	Revenues Revenues	1530223	usd
CY2023	us-gaap	Revenues Revenues	2409953	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	734285	usd
CY2023	us-gaap	Gross Profit GrossProfit	1675668	usd
CY2023	mssv	Percentage Of Gross Profit PercentageOfGrossProfit	0.6953	pure
CY2023Q4	us-gaap	Assets Assets	2879103	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-9813666	usd
CY2019Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.2
CY2019Q4	mssv	Aggregate Exchange Amount AggregateExchangeAmount	97252	usd
CY2023	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	9850	usd
CY2022	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	15000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9917	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18437	usd
CY2023	mssv	Outstanding Convertible Notes OutstandingConvertibleNotes	9850	usd
CY2022	mssv	Outstanding Convertible Notes OutstandingConvertibleNotes	15000	usd
CY2019Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P4Y
CY2019Q4	mssv	Promissory Note Premium Interest PromissoryNotePremiumInterest	0.20	pure
CY2020Q4	mssv	Penalty Penalty	5379624	usd
CY2020Q4	mssv	Aggregate Principal Amount AggregatePrincipalAmount	5379624	usd
CY2020Q4	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.15	pure
CY2020Q4	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	15000000	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03
CY2020	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	262376	usd
CY2023Q4	mssv	Secured Note Exchange SecuredNoteExchange	2506827	usd
CY2023Q4	mssv	Aggregate Consideration AggregateConsideration	300000	usd
CY2020Q4	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	110000	usd
CY2020Q4	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.15	pure
CY2020Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P2Y
CY2020Q4	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	1000000	shares
CY2020Q4	mssv	Advance From Lender AdvanceFromLender	100000	usd
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	10000	usd
CY2020Q4	mssv	Warrants Issued WarrantsIssued	1000000	shares
CY2020Q4	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	17491	usd
CY2021Q1	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	1000000	usd
CY2021Q1	mssv	Annual Interest Rate AnnualInterestRate	0.15	pure
CY2021Q1	us-gaap	Long Term Debt Term LongTermDebtTerm	P1Y
CY2021Q1	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	10000000	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03
CY2021Q1	mssv	Advance From Lender AdvanceFromLender	900000	usd
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	100000	usd
CY2023Q4	mssv	Warrants Issued WarrantsIssued	10000000	shares
CY2023	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	237811	usd
CY2021Q2	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	11600000	usd
CY2021Q2	mssv	Annual Interest Rate AnnualInterestRate	0.12	pure
CY2021Q2	us-gaap	Long Term Debt Term LongTermDebtTerm	P3Y
CY2021Q2	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	70000000	shares
CY2021Q2	mssv	Advance From Lender AdvanceFromLender	10500000	usd
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1100000	usd
CY2021Q2	mssv	Warrants Issued WarrantsIssued	70000000	shares
CY2021Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	5465726	usd
CY2021Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	20991	usd
CY2021Q3	mssv	Interest Rate InterestRate	0.0899	pure
CY2021Q3	mssv	Interest Monthly Payments InterestMonthlyPayments	504.94	usd
CY2021Q3	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	1100000	usd
CY2021Q3	mssv	Annual Interest Rate AnnualInterestRate	0.12	pure
CY2021Q3	us-gaap	Long Term Debt Term LongTermDebtTerm	P3Y
CY2021Q3	mssv	Cashless Warrants Purchased CashlessWarrantsPurchased	7500000	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.085
CY2021Q3	mssv	Advance From Lender AdvanceFromLender	1000000	usd
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	100000	usd
CY2021Q3	mssv	Warrants Issued WarrantsIssued	7500000	shares
CY2022Q4	mssv	Participating Mortgage Loan Unamortized Debt Discount Amount ParticipatingMortgageLoanUnamortizedDebtDiscountAmount	139	usd
CY2021Q4	mssv	Promissory Bebentures Lender Amount PromissoryBebenturesLenderAmount	84000	usd
CY2021Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	22162	usd
CY2021Q4	mssv	Premium Percent PremiumPercent	0.05	pure
CY2021Q3	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	360607	usd
CY2023	mssv	Outstanding Loan OutstandingLoan	7958	usd
CY2022	mssv	Outstanding Loan OutstandingLoan	7958	usd
CY2023Q4	mssv	Participating Mortgage Loan Unamortized Debt Discount Amount ParticipatingMortgageLoanUnamortizedDebtDiscountAmount	0	usd
CY2021Q4	us-gaap	Premiums Earned Net Life PremiumsEarnedNetLife	111470	usd
CY2021Q4	mssv	Debt Instrument Bears Interest Rate DebtInstrumentBearsInterestRate	0.12	pure
CY2021Q4	us-gaap	Long Term Debt Term LongTermDebtTerm	P17M
CY2023Q4	mssv	Aggregate Principal Amount AggregatePrincipalAmount	1999999	usd
CY2023Q4	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.06	pure
CY2023	mssv	Promissory Notes Payable PromissoryNotesPayable	19730.731	usd
CY2022	mssv	Promissory Notes Payable PromissoryNotesPayable	20237559	usd
CY2023	mssv	Promissory Notes Payable Discount PromissoryNotesPayableDiscount	2100966	usd
CY2022	mssv	Promissory Notes Payable Discount PromissoryNotesPayableDiscount	5117631	usd
CY2023Q4	us-gaap	Other Deferred Costs Gross OtherDeferredCostsGross	15798	usd
CY2022Q4	us-gaap	Other Deferred Costs Gross OtherDeferredCostsGross	49132	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	17613966	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	15070796	usd
CY2023	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	300000	usd
CY2022	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	5776	usd
CY2023Q4	us-gaap	Amortization Expense Per Dollar Of Gross Revenue AmortizationExpensePerDollarOfGrossRevenue	3049999	usd
CY2022Q4	us-gaap	Amortization Expense Per Dollar Of Gross Revenue AmortizationExpensePerDollarOfGrossRevenue	1738327	usd
CY2023Q4	mssv	Outstanding Promissory Notes Payable OutstandingPromissoryNotesPayable	19730731	usd
CY2022Q4	mssv	Outstanding Promissory Notes Payable OutstandingPromissoryNotesPayable	20237559	usd
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	293973	shares
CY2023Q4	us-gaap	Share Price SharePrice	0.0073
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.06
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0475	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.83	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	20442	usd
CY2022	mssv	Gain Loss On Derivative Fair Value Instruments GainLossOnDerivativeFairValueInstruments	10856	usd
CY2022	mssv	Derivative Instruments Conversions DerivativeInstrumentsConversions	-2642	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	6944	usd
CY2023	mssv	Gain Loss On Derivative Fair Value Instruments GainLossOnDerivativeFairValueInstruments	3450	usd
CY2023	mssv	Derivative Instruments Conversions DerivativeInstrumentsConversions	1348	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	2146	usd
CY2020	mssv	Issuance Of Warrants IssuanceOfWarrants	16000000	shares
CY2021Q1	mssv	Issuance Of Warrants IssuanceOfWarrants	10000000	shares
CY2021Q1	mssv	Warrants Issued For Debt WarrantsIssuedForDebt	237811	usd
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2021Q2	mssv	Issuance Of Warrants IssuanceOfWarrants	70000000	shares
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	308697	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	96135	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	359303	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	186269	usd
CY2023	us-gaap	Depreciation Depreciation	212562	usd
CY2022	us-gaap	Depreciation Depreciation	55199	usd
CY2021Q2	mssv	Warrants Issued For Debt WarrantsIssuedForDebt	5465726	usd
CY2021Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2021Q3	mssv	Issuance Of Warrants IssuanceOfWarrants	7500000	shares
CY2021Q3	mssv	Warrants Issued For Debt WarrantsIssuedForDebt	360607	usd
CY2023Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1000	shares
CY2023	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.8
CY2022Q1	mssv	Monthly Based On Annual Rate MonthlyBasedOnAnnualRate	90000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	503552	usd
CY2022Q1	mssv	Monthly Based On Annual Rate MonthlyBasedOnAnnualRate	90000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	896	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	448	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	448	shares
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.275	pure
CY2023Q4	us-gaap	Area Of Land AreaOfLand	1647	sqm
CY2023	mssv	Monthly Rent MonthlyRent	2714	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	5588	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	53451	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	44097	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	487700	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	487700	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	231156	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	133616	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	256544	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	354084	usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2023	mssv	Amortization Expense Intellectual Property AmortizationExpenseIntellectualProperty	97540	usd
CY2022	mssv	Amortization Expense Intellectual Property AmortizationExpenseIntellectualProperty	97540	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2060870	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1190032	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	870838	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5292725	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4421887	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5292725	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4421887	usd
CY2023	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	$26,386,980
CY2023	mssv	Monthly Rent MonthlyRent	2714	usd
CY2023Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	5588	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2714	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2714	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2714	usd
CY2021Q3	mssv	Stock Purchase Percentage StockPurchasePercentage	1	pure
CY2021Q3	us-gaap	Cash Cash	225000	usd
CY2023	mssv	Purchase Price PurchasePrice	6229000	usd
CY2023Q4	us-gaap	Cash Cash	175000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	5805438	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5805438	usd
CY2023	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	4125460	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1679978	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4125460	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1679978	usd
CY2022	us-gaap	Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Net Of Tax DiscontinuedOperationAmountOfAdjustmentToPriorPeriodGainLossOnDisposalNetOfTax	68313	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	24991	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	23024	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	1967	usd
CY2022	mssv	Disposal Group Including Discontinued Operation Advertising And Marketing DisposalGroupIncludingDiscontinuedOperationAdvertisingAndMarketing	117	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	1400	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	67864	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	-66347	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	68313	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax		usd
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.46
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.79
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2022	mssv	Gain On Settlement Of Debt GainOnSettlementOfDebt		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2023	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations		usd
CY2023	mssv	Gainloss On Discontinued Operations GainlossOnDiscontinuedOperations		usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2022	mssv	Consideration Paid To Note Holder ConsiderationPaidToNoteHolder		usd
CY2023	mssv	Right Of Use Asset Financed Through Payable RightOfUseAssetFinancedThroughPayable		usd
CY2022	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions		usd
CY2023	us-gaap	Servicing Asset At Fair Value Additions ServicingAssetAtFairValueAdditions		usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest		usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001760026
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023	dei	Security Exchange Name SecurityExchangeName	NONE

Files In Submission

Name	View Source	Status
0001213900-24-032991-index-headers.html	Edgar Link	pending
0001213900-24-032991-index.html	Edgar Link	pending
0001213900-24-032991.txt	Edgar Link	pending
0001213900-24-032991-xbrl.zip	Edgar Link	pending
ea0203857-10k_meso.htm	Edgar Link	pending
ea020385701ex3-8_meso.htm	Edgar Link	pending
ea020385701ex3-9_meso.htm	Edgar Link	pending
ea020385701ex31-1_meso.htm	Edgar Link	pending
ea020385701ex31-2_meso.htm	Edgar Link	pending
ea020385701ex32-1_meso.htm	Edgar Link	pending
ex3-8_001.jpg	Edgar Link	pending
ex3-8_002.jpg	Edgar Link	pending
ex3-9_001.jpg	Edgar Link	pending
ex3-9_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mssv-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mssv-20231231_cal.xml	Edgar Link	unprocessable
mssv-20231231_def.xml	Edgar Link	unprocessable
mssv-20231231_lab.xml	Edgar Link	unprocessable
mssv-20231231_pre.xml	Edgar Link	unprocessable
ea0203857-10k_meso_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMTG
Regenerative Medical Technology Group Inc. Stock $rmtg

2024 Q1 Form 10-K Financial Statement

#000121390024032991 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTG Regenerative Medical Technology Group Inc. Stock $rmtg

2024 Q1 Form 10-K Financial Statement

#000121390024032991 Filed on April 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTG
Regenerative Medical Technology Group Inc. Stock $rmtg